ArticleMolecular and clinical oncology2022

Outcomes of high‑dose methotrexate for CNS prophylaxis in diffuse large B‑cell lymphoma with an intermediate or high CNS‑International Prognostic Index: A single‑center retrospective cohort study.

Mubarak Al-Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.